Selecting triple negative breast cancer patients for immunotherapy Review

  

Authors:	Downs-Canner, S.; Mittendorf, E. A.
Review Title:	Selecting triple negative breast cancer patients for immunotherapy
Keywords:	event free survival; cancer surgery; review; cancer combination chemotherapy; patient selection; treatment duration; cancer patient; preoperative care; neoadjuvant therapy; cancer staging; cancer immunotherapy; breast cancer; cancer screening; immunotherapy; early cancer; screening; clinical evaluation; comorbidity; preoperative treatment; metastatic breast cancer; immunopathology; neoadjuvant; programmed death 1 ligand 1; adverse event; triple negative breast cancer; immune checkpoint inhibitor; humans; human; pembrolizumab; triple negative breast neoplasms; immune checkpoint protein
Journal Title:	Surgical Oncology Clinics of North America
Volume:	32
Issue:	4
ISSN:	1055-3207
Publisher:	Elsevier Inc.
Date Published:	2023-10-01
Start Page:	733
End Page:	745
Language:	English
DOI:	10.1016/j.soc.2023.05.005
PUBMED:	37714640
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85161005190&doi=10.1016%2fj.soc.2023.05.005&partnerID=40&md5=e9bca1508aa9dcadfd660a177b8b1d2d
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/210078